| Topics | Speakers | Time | Venue |
|---|---|---|---|
| WELCOME |
|
07.50 | |
| VENOUS I | 08.00-08.48 | Session 1 | |
| A minimally invasive techinique of open saphenectomy. How I do it |
|
08.00 | |
| Advances in the treatment of venous insufficiency with dense foam sclerotherapy |
|
08.05 | |
| Choosing between superficial venous interventions in modern venous practice |
|
08.10 | |
| Modern sclerotherapy: what has changed? |
|
08.15 | |
| Foam sclerotherapy and the Brazilian Public Health System: 10-year results |
|
08.20 | |
| Why polidocanol endovenous microfoam (PEM) is becoming the gold standard treatment modality for symptomatic refluxing superficial veins despite limited long-term results |
|
08.25 | |
| Cianoacrylate: from patient selection to long-term outcomes |
|
08.30 | |
| Discussion | 08.35 | ||
| PERIPHERAL ARTERIAL DISEASE I | 08.50-09.33 | Session 2 | |
| In stent restenosis after drug eluting stent in the superficial femoral artery: plaque morphology comparison between different platforms |
|
08.50 | |
| Lower limb revascularization by means of thrombectomy with specific devices |
|
08.55 | |
| Endovascular PTA and stenting of deep femoral artery lesions is possible and effective |
|
09.00 | |
| Preventive IMA embolization: a key role in AAA sac management? |
|
09.05 | |
| When innovation meets real-world challenges in SFA treatment |
|
09.10 | |
| Optimizing treatment of calcified PAD: the critical role of vessel preparation |
|
09.15 | |
| Discussion | 09.20 | ||
| CRITICAL TOPICS IN ARTERIAL SURGERY | 09.35-10.23 | Session 3 | |
| Oncovascular surgery: role of the vascular surgeon in the treatment of neoplastic lesions |
|
09.35 | |
| Does omentoplasty at index open aortic repair prevent from infection and aortoenteric fistula? |
|
09.40 | |
| Modern management of Median Arcuate Ligament Syndrome (MALS) |
|
09.45 | |
| Cadaver lab testing in preclinical evaluation of new devices, the key role of skilled independent physicians |
|
09.50 | |
| Off-IFU versus IFU-concordant low profile endograft use in endovascular aneurysm repair: IFU adherence, sac remodeling, and mid-term outcomes |
|
09.55 | |
| Discussion | 10.00 | ||
| KEYNOTE LECTURE | Open renal artery reconstructions in endovascular era |
|
10.13 | |
| PERIPHERAL ARTERIAL DISEASE II | 10.25-11.18 | Session 4 | |
| Retrospective multicenter study of below the knee revascularization in the absence of saphenous vein: comparison of prosthetic bypass and endovascular treatment |
|
10.25 | |
| Peroneal artery bypass for limb salvage in chronic limb-threatening ischemia: a multicenter 5-year experience |
|
10.30 | |
| Extreme retrograde punctures |
|
10.35 | |
| Hybrid treatment of aorto-iliac occlusive disease |
|
10.40 | |
| Current options for revascularization of the ischemic diabetic foot: what has changed in recent years |
|
10.45 | |
| The emerging role of bioresorbable scaffolds in BTK disease: clinical aspects and latest evidences |
|
10.50 | |
| Discussion | 10.55 | ||
| KEYNOTE LECTURE | Distal and ultra distal bypass after failed endo: challenges and solutions |
|
11.08 | |
| VASCULAR EMERGENCIES I | 11.20-12.08 | Session 5 | |
| SVS blunt thoracic aortic injury. Clinical practice guidelines 2.0 |
|
11.20 | |
| Current controversies on blunt aortic trauma |
|
11.25 | |
| Blunt traumatic aortic injuries in 2026: when to intervene, when to wait, and how to do it safely |
|
11.30 | |
| Complex aortic emergencies: from silent killer to surgical success |
|
11.35 | |
| Long-term outcomes and cardiovascular remodeling after TEVAR for blunt thoracic aortic injury |
|
11.40 | |
| Discussion | 11.45 | ||
| KEYNOTE LECTURE | Vascular trauma: an evolution in therapy |
|
11.58 | |
| ARTERIAL / CAROTID | 12.10-13.00 | Session 6 | |
| Carotid body tumor: the San Raffaele experience |
|
12.10 | |
| From CEA to TCAR to CAS. A high volume surgeon journey on carotid disease over last 20 years |
|
12.15 | |
| Micromesh stent for CAS |
|
12.20 | |
| Are the CREST-2 results reliable to change clinical practice in patients with asymptomatic carotid stenosis? |
|
12.25 | |
| Visceral artery aneurysms: insights from the European Visceral Artery Revascularization (EVisAR) study |
|
12.30 | |
| Carotid body tumor: hybrid approach |
|
12.35 | |
| The endless dilemma in the treatment of asymptomatic carotid disease: did CREST-2 change our paradigm? |
|
12.40 | |
| Discussion | 12.45 | ||
| SPECIAL LECTURE | Priorities in managing a major emergency involving 12 subjects with severe burns |
|
13.00 |